Clinical Validation of ColonAiQ (a Blood-based Assay Targeting ctDNA Methylation) for Colorectal Cancer Detection

NCT06347887 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1965

Last updated 2024-06-03

No results posted yet for this study

Summary

The DNA methylation targets in preoperative plasma samples of the subjects will be detected by the multi-gene methylation test (ColonAiQ), and the test accuracy will be evaluated by compared with the clinical diagnosis evidence.

Conditions

Interventions

DIAGNOSTIC_TEST

ColonAiQ test and Colonoscopy

Diagnostic Test

Sponsors & Collaborators

  • Singlera Genomics Inc.

    lead INDUSTRY

Principal Investigators

  • Guoxiang Cai, M.D. Ph.D. · Fudan University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-31
Primary Completion
2024-01-16
Completion
2024-01-16

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06347887 on ClinicalTrials.gov